Relay Therapeutics, Inc. RLAY Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s retained earnings?
- Relay Therapeutics, Inc. (RLAY) reported retained earnings of -$2.09B in Q1 2026.
- How has Relay Therapeutics, Inc.'s retained earnings changed year-over-year?
- Relay Therapeutics, Inc.'s retained earnings decreased by 15.0% year-over-year, from -$1.82B to -$2.09B.
- What is the long-term trend for Relay Therapeutics, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s retained earnings has grown at a 37.9% compound annual growth rate (CAGR), from -$404.23M to -$2.01B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.